Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor- infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3978-3988

  Yoong, Khong F ^a   McNab, Gillian ^a   Hübscher, Stefan G ^b   Adams, David H ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 1;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SHEAR STRESS; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; ENDOTHELIUM; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; LIVER NEOPLASMS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0032522844     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Robbins, P. F., and Y. Kawakami. 1996. Human tumor antigens recognised by T-cells. Curr. Opin. Immunol. 8:628.
2. Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P. F. Robbins, F. M. Marincola, M. L. Salgaller, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154: 2257.
3. Yannelli, J. R. 1991. The preparation of effector cells for use in the adoptive cellular therapy of cancer. J. Immunol. Methods 139:1.
4. Rosenberg, S. A., J. R. Yannelli, J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, J. S. Weber, D. R. Parkinson, C. A. Seipp, J. N. Einhorn, and D. E. White. 1994. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst. 86:1159.
5. Escudier, B., A. Ravaud, M. Fabbro, J. Y. Douillard, S. Negrier, C. Chevreau, L. Mignot, D. Baume, T. Dorval, F. Vignal, F. Farace, and D. Maraninchi. 1994. High-dose interleukin-2 2 days a week for metastatic renal-cell carcinoma: a FNCLCC multicenter study. J. Immunother. 16:306.
6. Finke, J. H., P. Rayman, L. Hart, J. P. Alexander, M. G. Edinger, R. R. Tubbs, E. Klein, L. Tuason, and R. M. Bukowski. 1994. Characterization of tumor-infiltrating lymphocyte subsets from human renal-cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J. Immunother. 15:91.
7. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognised by cytolytic T lymphocytes on a human melanoma. Science 2:1643.
8. Adams, D. H., and S. Shaw. 1994. Leucocyte endothelial interactions and regulation of leucocyte migration. Lancet 343:831.
9. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
10. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
11. Lasky, L. A. 1992. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964.
12. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. Vonandrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. Alpha-4 integrins mediate lymphocyte attachment and rolling under physiological flow. Cell 80:413.
13. Jones, D. A., L. V. McIntire, C. W. Smith, and L. J. Picker. 1994. A 2-step adhesion cascade for T cell endothelial-cell interactions under flow conditions. J. Clin. Invest. 94:2443.
14. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
15. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1? Nature 361:79.
16. Airas, L., J. Hellman, M. Salmi, P. Bono, T. Puurunen, D. J. Smith, and S. Jalkanen. 1995. Cd73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte vascular adhesion protein-2 identifies it as cd73. J. Exp. Med. 182:1603.
17. Mackay, C. R. 1996. Chemokine receptors and T-cell chemotaxis. J. Exp. Med. 184:799.
18. Hedrick, J. A., and A. Zlotnik. 1996. Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8:343.
19. Picker, L. J., J. R. Treer, B. Ferguson-Darnell, P. A. Collins, P. R. Bergstresser, and L. W. M. M. Terstappen. 1993. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J. Immunol. 150:1122.
20. Adams, D. H., S. G. Hubscher, N. C. Fisher, A. Williams, and M. Robinson. 1996. Expression of E-selectin (CD62E) and E-selectin ligands in human liver inflammation. Hepatology 24:533.
21. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamman, and E. C. Butcher. 1993. Alpha 4 beta 7 integrin mediates binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.
22. + memory T cells with hallmarks of gut-trophism. J. Immunol. 151:717.
23. McNab, G., J. L. Reeves, M. Salmi, S. G. Hubscher, S. Jalkanen, and D. H. Adams. 1996. Vascular adhesion protein-1 supports adhesion of T lymphocytes to hepatic endothelium: a mechanism for T cell recirculation to the liver? Gastroenterology 110:522.
24. Henkart, P. A. 1985. Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 3:31.
25. Liu, D. L., C. H. Hakansson, and J. Seifert. 1994. Immunotherapy in liver-tumors. II. Intratumoral injection with activated tumor-infiltrating lymphocytes, intrasplenic administration of recombinant interleukin-2 and interferon-alpha causes tumor-regression and lysis. Cancer Lett. 85:39.
26. Shimizu, Y., S. Iwatsuki, R. B. Herberman, and T. L. Whiteside. 1990. Clonal analysis of tumour infiltrating lymphocytes from human primary and metastatic liver tumours. Int. J. Cancer 46:878.
27. Adams, D. H., P. Burra, S. G. Hubscher, E. Elias, and W. Newman. 1994. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 19:588.
28. Yoong, K. F., and D. H. Adams. 1997. Interleukin-2 restores CD3 zeta chain expression but fails to generate specific cytolytic activity in tumor infiltrating lymphocytes from patients with hepatic colorectal metastases. Br. J. Cancer. In press.
29. McNab, G., S. C. Afford, C. M. Morland, A. J. Strain, R. Joplin, and D. H. Adams. 1997. Cultured human hepatic sinusoidal endothelial cells express and secrete adhesion molecules and chemokines that are important for leukocyte recruitment to the liver. In Cells of the Hepatic Sinusoid, E. Wisse, D. L. Knook, and C. Balabaud, eds. The Kupffer Cell Foundation, Leiden, p. 123.
30. Morland, C. M., J. Fear, G. McNab, R. Joplin, and D. H. Adams. 1997. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc. Assoc. Am. Physicians 109:372.
31. Knook, D. L., C. Barkway, and E. C. Sleyster. 1981. Lysosomal enzyme content of Kupffer and endothelial liver-cells isolated from germ-free and clean conventional rats. Infect. Immun. 33:620.
32. Adams, D. H., J. Yannelli, W. Newman, S. A. Rosenberg, and S. Shaw. 1997. Adhesion of tumour-infiltrating lymphocytes to endothelium: a functional and phenotypic analysis. Br. J. Cancer 75:1421.
33. Salmi, M., K. Granfors, M. Leirisalo-Repo, M. Hamalainen, R. MacDermott, R. Leino, T. Havia, and S. Jalkanen. 1992. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc. Natl. Acad. Sci. USA 89:11436.
34. Salmi, M., and S. Jalkanen. 1992. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257:1407.
35. Shimizu, Y., W. Newman, T. V. Gopal, K. J. Horgan, N. Graber, L. D. Beall, G. A. van Seventer, and S. Shaw. 1991. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell Biol. 113:1203.
36. Salmi, M., S. Tohka, E. L. Berg, E. C. Butcher, and S. Jalkanen. 1997. Vascular adhesion protein 1 mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J. Exp. Med. 186: 598.
37. Salmi, M., and S. Jalkanen. 1996. Human vascular adhesion protein-1 (vap-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial-cells. J. Exp. Med. 183:569.
38. Spertini, O., F. W. Luscinskas, G. S. Kansas, J. M. Munro, J. D. Griffin, M. A. Gimbrone, Jr., and T. F. Tedder. 1991. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J. Immunol. 147:2565.
39. Takagi, S., K. Chen, R. Schwarz, S. Iwatsuki, R. B. Herberman, and T. L. Whiteside. 1989. Functional and phenotypic analysis of tumor infiltrating lymphocytes isolated from human primary and metastatic liver tumours and cultured in recombinant interleukin-2. Cancer 63:102.
40. Mackensen, A., G. Carcelain, S. Viel, M. C. Raynal, H. Michalaki, F. Triebel, J. Bosq, and T. Hercend. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1397.
41. Straten, P., J. C. Becker, T. Seremet, E. B. Brocker, and J. Zeuthen. 1996. Clonal T-cell responses in tumor-infiltrating lymphocytes from both regressive and progressive regions of primary human-malignant melanoma. J. Clin. Invest. 98:279.
42. Whiteside, T. L., and R. B. Herberman. 1992. Extravasation of antitumor effector cells. Invasion Metastasis 12:128.
43. Volpes, R., J. J. van den Oord, and V. J. Desmet. 1992. Vascular adhesion molecules in acute and chronic liver disease. Hepatology 15:269.
44. Steinhoff, G., M. Behrend, B. Schrader, A. M. Duijvestijn, and K. Wonigeit. 1993. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia: lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3. Am. J. Pathol. 142:481.
45. Adams, D. H. 1996. Lymphocyte-endothelial interactions in hepatic inflammation. Hepato-Gastroenterology 43:32.
46. Friedman, S. L., J. S. Flier, F. Epstein, R. Glickman, and G. Scheele. 1993. Seminars in medicine of the Beth-Israel-Hospital, Boston: the cellular basis of hepatic-fibrosis: mechanisms and treatment strategies. N. Engl. J. Med. 328:1828.
47. Kantele, J. M., H. Arvilommi, S. Kontiainen, M. Salmi, S. Jalkanen, E. Savilahti, M. Westerholm, and A. Kantele. 1996. Mucosally activated circulating human B-cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology 110:1061.
48. Wong, J., B. Johnston, S. S. Lee, D. C. Bullard, C. W. Smith, A. L. Beaudet, and P. Kubes. 1997. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest. 99:2782.
49. Piali, L., A. Fichtel, H. Terpe, B. A. Imhof, and R. H. Gisler. 1995. Endothelial VCAM-1 expression is suppressed by melanoma and carcinoma. J. Exp. Med. 181:811.
50. Salmi, M., K. Kalimo, and S. Jalkanen. 1993. Induction and function of vascular adhesion protein 1 at sites of inflammation. J. Exp. Med. 178:2255.
51. Arvilommi, A. M., M. Salmi, K. Kalimo, and S. Jalkanen. 1996. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (vap-1). Eur J. Immunul 26:825.
52. Mise, M., S. Arii, H. Higashituji, M. Furutani, M. Niwano, T. Harada, S. Ishigami, Y. Toda, H. Nakayama, M. Kukumoto, J. Fujita, and M. Imamura. 1996. Clinical significance of vascular endothelial cell growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23:455.
53. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:4494.
54. Bargatze, R. F., M. A. Jutila, and E. C. Butcher. 1995. Distinct roles of L-selectin and integrins alpha-4-beta-7 and LFA-1 in lymphocyte homing to Peyers patch-HEV in-situ: the multistep model confirmed and refined. Immunity 3:99.
55. Cepek, K. L., S. K. Shaw, C. M. Parker, G. J. Russell, J. S. Morrow, D. L. Rimm, and M. B. Brenner. 1994. Adhesion between epithelial-cells and T-lymphocytes mediated by E-cadherin and the alpha(e)beta(7) integrin. Nature 372:190.
56. DeVries, J. E., W. N. M. Dinjens, G. K. Debruyne, H. W. Verspaget, E. P. M. Vanderlinden, A. P. Debruine, M. M. Mareel, F. T. Bosnian, and J. Tenkate. 1995. In-vivo and in-vitro invasion in relation to phenotypic characteristics of human colorectal-carcinoma cells. Br. J. Cancer 71:271.
57. Gagliardi, G., O. Kandemir, D. Liu, M. Guida, S. Benvestito, T. G. M. Ruers, I. S. Benjamin, J. M. A. Northover, G. W. H. Stamp, I. C. Talbot, and M. Pignatelli. 1995. Changes in E-cadherin immunoreactivity in the adenomacarcinoma sequence of the large-bowel. Virchows Arch. A Pathol. Anat. Histopathol. 426:149.
58. Pockaj, B. A., R. M. Sherry, J. P. Wei, J. R. Yannelli, C. S. Carter, S. F. Leitman, J. A. Carasquillo, S. M. Steinberg, S. A. Rosenberg, and J. C. Yang. 1994. Localization of indium-111-labeled tumor-infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Cancer 73:1731.